GARRY LOVINS: Open Payments
NPI 1427517986 · CLARKSVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$620 in 5 payments from 4 companies in 2025. Trend: 2023 $235 · 2024 $235 · 2025 $620
Food & beverage: $620
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 2 | $277 |
| Novo Nordisk Inc | 1 | $120 |
| Actelion Pharmaceuticals US, Inc. | 1 | $120 |
| Ardelyx, Inc. | 1 | $103 |
Products named: REZDIFFRA, Wegovy, UPTRAVI, IBSRELA.
Industry payments across MD — which companies pay providers there.
